KW-2149 (KT-6149) is a Mitomycin C (HY-13316) analogue activated by serum. KW-2149 can interact with DNA. KW-2149 exhibits antitumor activity. KW-2149 has pulmonary toxicity KW-2149 can be used for the research of cancer, such as leukemia[1][2].
Molekulargewicht:
598.69
CAS Nummer:
[118359-59-4]
Formel:
C24H34N6O8S2
Target-Kategorie:
DNA Alkylator/Crosslinker,Drug Derivative
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten